Heart and lung side effects from radiation for lung cancer
Part of Cancer, Heart & circulation, Lungs & breathing clinical trials.
This study looks at medical images and health records from people treated with radiation for early-stage non-small cell lung cancer to better understand how radiation affects the heart and lungs. This could help doctors prevent side effects in future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were diagnosed with non-small cell lung cancer at stage I, II, or III.
- You received radiation therapy as part of your treatment, with or without chemotherapy.
- You did not have surgery to remove part or all of your lung before radiation.
- Your medical records and imaging are available for the study.
- You are at least 18 years old.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking back at the medical records of people with early-stage non-small cell lung cancer who had surgery or radiation therapy between 2018 and 2019. The goal is to understand how patients were diagnosed and treated, which may help improve care for others in the future.
This study looks at how chest radiation treatment affects the heart and lungs in people with certain lung or esophagus cancers. It may help doctors better predict and prevent these side effects during curative (aimed at cure) radiotherapy.
This study monitors how the heart and lungs respond to radiation therapy combined with immunotherapy for locally advanced lung cancer. It aims to learn how well patients tolerate treatment and to detect early signs of side effects.
This study looks at how radiation therapy affects the heart in people being treated for lung, esophageal, or breast cancer. By watching the heart during and after treatment, researchers hope to find ways to lower heart side effects.
This study tests a new way of planning radiation therapy for stage 3 lung cancer. By carefully mapping the heart's structure, doctors aim to protect it from radiation and improve treatment safety.
This study tests whether giving radiation to tumors in the chest soon after starting systemic therapy can help prevent symptoms like pain, trouble breathing, or bleeding. It is for people with advanced non-small cell lung cancer that does not have certain gene changes and has high-risk tumors in the chest.
Hear when a new NSCLC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.